3'-o-(4-benzoyl)benzoyladenosine 5'-triphosphate has been researched along with Bipolar Disorder in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aluisio, L; Ao, H; Bhattacharya, A; Bonaventure, P; Fraser, I; Letavic, MA; Lord, B; Lovenberg, TW; Neff, RA; Nepomuceno, D; Shoblock, JR; Wang, Q; Welty, N; Wickenden, AD | 1 |
1 other study(ies) available for 3'-o-(4-benzoyl)benzoyladenosine 5'-triphosphate and Bipolar Disorder
| Article | Year |
|---|---|
Pharmacological characterization of a novel centrally permeable P2X7 receptor antagonist: JNJ-47965567.
Topics: Adenosine Triphosphate; Analgesics; Animals; Antidepressive Agents; Antimanic Agents; Behavior, Animal; Binding, Competitive; Bipolar Disorder; Blood-Brain Barrier; Brain; Calcium Signaling; Capillary Permeability; Cell Line; Depression; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Humans; Interleukin-1beta; Macaca; Male; Mice; Mice, Inbred C57BL; Neuralgia; Niacinamide; Piperazines; Protein Binding; Purinergic P2X Receptor Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P2X7; Time Factors; Transfection | 2013 |